Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited)

v3.10.0.1
Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Statement Line Items [Line Items]        
Revenue
Expenses:        
Research and development (note 9) 7,818 1,088 10,958 2,823
General and administrative (note 9) 2,511 1,393 6,213 2,983
Operating Expenses 10,329 2,481 17,171 5,806
Finance expense (note 9) 11 29
Finance income (note 9) (74) (40) (118) (73)
Net finance income (63) (40) (89) (73)
Net loss and comprehensive loss for the period $ (10,266) $ (2,441) $ (17,082) $ (5,733)
Basic and diluted loss per common share (in dollars per share) $ (0.30) $ (0.11) $ (0.56) $ (0.30)
Weighted average number of common shares outstanding used in the calculation of basic and diluted loss per common share (000’s) note 6(b)) (in shares) 33,950 21,309 30,744 19,375